Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Emerging Therapy

Johnson & Johnson COVID-19 Vaccine List of Ingredients

What We Know About PEG, Suspected as the Cause of Reactions to Pfizer’s COVID-19 Vaccine

Moderna COVID-19 Vaccine List of Ingredients

Nanoparticle Appears to Prevent, Treat Peanut Allergies in Mice

Food Allergies Reversed in Mice by Targeting the Microbiome

DBV Completes Phase III Study of Peanut Patch

Institute Receives $5M Grant to Study Personalized Treatments for Peanut Allergy

Oral Immunotherapy: What You Should Know, and What’s New (Webinar)

Nestlé Partners with DBV to Develop Milk Allergy Test

Government Shutdown Delays Review of AR101 Peanut Oral Immunotherapy Candidate

Adult Peanut Allergy: Therapy Cleared to Begin Phase IIa Trials

New Treatment to Protect People with Peanut Allergies Ready for FDA...

FDA Grants Kaleo Priority Review Status for Auvi-Q Designed for Infants...

Mabylon’s Drug Candidate Promises Lasting Protection for Peanut Allergy

Peanut Sublingual Immunotherapy Shows Long-Term Benefits for Young Children

Your School On Our Map

Put Your School on the Map